Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking an Executive Medical Director, GI, Europe to provide strategic medical leadership across the European region for the GI oncology portfolio. The role will be responsible for defining and executing the Regional medical strategy in alignment with global objectives, ensuring scientific excellence, patient- centricity, and compliance.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines